{
 "PrintNo":"A5914","Version":"A","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly",
 "Published":"2023-03-24T10:23:40.768541Z","Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-03-24","Chamber":"ASSEMBLY"},
  {"Text":"AMEND AND RECOMMIT TO HEALTH","Date":"2023-11-01","Chamber":"ASSEMBLY"},
  {"Text":"PRINT NUMBER 5914A","Date":"2023-11-01","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"ASSEMBLY","Version":"A"}
 ],
 "Sponsors":[{"ID":886,"Name":"Carrie Woerner","Short":"WOERNER"}],
 "Title":"Designates Xylazine as a schedule III depressant",
 "Summary":"Designates Xylazine as a schedule III depressant.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to designating Xylazine as a schedule III depressant",
 "SameAsPrintNo":"S5439-2023"
}